In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

Need help?

Read the Frequently Asked Questions for a better use

Read more

 

Refine your search
Sponsor

ESC Congress 365

All ESC Congress resources in one online library

View thousands of videos, slides, abstracts and reports from the world's largest cardiovascular congress – anytime!

Any question or suggestion? Check the Frequently Asked Questions or send it to us by email.

 

 

ESC Congress 365 only features abstracts, slides, reports and/or videos for which the speakers and/or presenters have granted the European Society of Cardiology the rights to use for educational purposes.

presentations found.

SPONSORED RESOURCES

Presentations below are part of sessions supported by Daiichi Sankyo Europe GmbH.

Daiichi Sankyo Europe GmbH
Abstract Slides/e-posters Video Report ESC TV Interview
 
What do we need to take into account when selecting among the various non-vitamin K antagonist oral anticoagulants?
Presenter: A Goette (Paderborn,DE)
2015
more
 
Panel Discussion: non-vitamin K antagonist oral anticoagulants in atrial fibrillation - How to apply evidence from randomised clinical trials in daily practice.
Presenter: R De Caterina (Chieti,IT), C T Ruff (Boston,US), A Goette (Paderborn,DE)
2015
more
 
Fitting the non-vitamin K antagonist oral anticoagulant to the patient.
Presenter: C T Ruff (Boston,US)
2015
more
 
Stroke prevention in atrial fibrillation - Balancing benefits and bleeding risks with edoxaban in the ENGAGE AF-TIMI 48 trial.
Presenter: C T Ruff (Boston,US)
2015
more
 
Which non-vitamin K antagonist oral anticoagulant for which patient - Treatment algorithms for anticoagulation in atrial fibrillation.
Presenter: G Y H Lip (Birmingham,GB)
2015
more
 
Sub analysis from ENGAGE AF-TIMI 48 and confirmation in clinical practice.
Presenter: J Steffel (Zurich,CH)
2015
more
 
The pharmacology of edoxaban and the rationale for once daily anticoagulation.
Presenter: RK Kreutz (Berlin,DE)
2015
more
 
Which patient subgroups benefit most from treatment with non-vitamin K antagonist oral anticoagulants?
Presenter: R De Caterina (Chieti,IT)
2015
more
 
Welcome and Introduction - Edoxaban – Engaging with the real world in atrial fibrillation.
Presenter: C Bode (Freiburg,DE)
2015
more
 
Summary and meeting close - Hypertension care: it’s time to act.
Presenter: J Redon (Valencia,ES), A M Heagerty (Manchester,GB)
2014
more

The scientific programme has been prepared by the Congress Programme Committee in close collaboration with the ESC Working Groups, ESC Associations and the ESC Councils.

 

Daiichi Sankyo Europe GmbH